Straumann Group announces Board change in 2024
Straumann Group announces that its Chairman Gilbert Achermann has decided not to seek re-election as Chairman and Board…
Straumann Group announces that its Chairman Gilbert Achermann has decided not to seek re-election as Chairman and Board…
Long-term investment holding acquires majority stake in market leader of innovative planning software for endoprosth…
Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that…
CytoSorbents Corporation (NASDAQ: CTSO) beruft Jiny Kim zum neuen Mitglied im Board of Directors von CytoSorbents. Frau…
Jason Forbes joins as Straumann Group Chief Consumer Officer, a newly created position in the Executive Management B…
Winner of the Australian Global Innovation Linkages Program Funding dedicated to advancing regenerative scaffolds for br…
510(k) clearance of the TLIF cage is an important step towards progression of Fibrin-PTH product candidate KUR-113 into…
Global partner to market an advanced bone graft supplied by Kuros Agreement demonstrates interest of major orthobiologic…
Successfully raised CHF 16.1 million from existing and new investors Funding secured for fibrin-PTH Phase II in spinal f…
Kuros Biosciences, (SWX: KURN) a full-fledged orthobiologics company with scientific, clinical, and commercial excellenc…